Skip to main content
Clinical Trials/PACTR202110584772902
PACTR202110584772902
Not yet recruiting
Phase 1

Safety and efficacy of dexmedetomidine as adjuvant to fentanyl/midazolam combination for sedation of mechanically ventilated neurocritical care patients after head injury: A randomized controlled trial

amr sobhy0 sites38 target enrollmentSeptember 15, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
amr sobhy
Enrollment
38
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 15, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
amr sobhy

Eligibility Criteria

Inclusion Criteria

  • Age: 18 \- 70 years\-old
  • GCS: 8 \- 12 at the time of admission

Exclusion Criteria

  • Severe head injury (GCS less than 8\)
  • 2\.Any previous neurological insult
  • 3\.Severe brain edema or brain hemorrhage with midline shift
  • 4\.Severe polytrauma
  • 5\.Advanced liver or kidney disease
  • 6\.Uncontrolled diabetes, hypertension, or heart disease
  • 7\.History of chronic use of sedatives, narcotics, alcohol, or drug abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials